<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="66401">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02241447</url>
  </required_header>
  <id_info>
    <org_study_id>IMPULSE</org_study_id>
    <nct_id>NCT02241447</nct_id>
  </id_info>
  <brief_title>Quality of Care in AS IMPULSE Study</brief_title>
  <acronym>IMPULSE</acronym>
  <official_title>Study to Improve Outcomes in Aortic Stenosis. International, Multi-center, Prospective, Observation and Interventional Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut für Pharmakologie und Präventive Medizin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut für Pharmakologie und Präventive Medizin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to narrow the gap between patients being diagnosed with severe
      aortic stenosis and those being appropriately monitored and treated. For this purpose a
      prospective survey of current practice (3 months) will be conducted followed by a six month
      period of intervention during which a variety of quality improvements measures will be
      implemented. There will then be a 3 month follow-up period during which the legacy of this
      initiative will be monitored during which no intervention will be carried out.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients meeting pre-specified criteria (severe aortic stenosis whether with or without
      symptoms) will be collected. There will be three phases at each site observation A,
      intervention, observation B. Observation A: In this phase, the nurse identifies cases with
      severe AS at the hub AND the satellite and collects their data. Baseline data for each
      patient will be collected and a follow-up will be done after three months for each patient
      to determine his/her outcome and the treatment that was decided on. There will also be an
      optional telephone follow-up to find out the patient's outcome.

      Intervention: In this phase, the physician referring a patient for echocardiography will be
      notified of a finding of severe aortic stenosis: the nurse brings cases with severe AS to
      the attention of the referring physician within a week (via phone, e-mail or letter) to make
      them aware of the diagnosis.

      Baseline and follow-up data will be collected for each patient as before. Moreover, more
      detailed data with regard to the patient's health status will be documented.

      Observation B: Same as Observation Phase A
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Referral rates at 3 months for Intervention (SAVR or TAVI)</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Referral rates at 3 months for exercise testing or stress echocardiography</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to next out-patient appointment or clinical review</measure>
    <time_frame>15 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of intervention selected (SAVR, TAVI, watchful waiting or no treatment)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Appropriateness of treatment decisions made in collaboration with the valve specialist</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outcomes (survival) at 1 year (telephone FU) including the time between diagnosis and treatment</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <arm_group>
    <arm_group_label>Observation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>the nurse identifies cases with severe AS at the hub AND the satellite and collects their data. Baseline data for each patient will be collected and a follow-up will be done after three months for each patient to determine his/her outcome and the treatment that was decided on</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Early information</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>in this arm, the physician referring a patient for echocardiography will be notified of a finding of severe aortic stenosis: the nurse brings cases with severe AS to the attention of the referring physician within a week (via phone, e-mail or letter) to make them aware of the diagnosis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Early Information</intervention_name>
    <description>Nurse based at echo facility will inform referring physician within one week that their Patient was diagnosed with severe aortic Stenosis. outcomes and Treatment decision will be documented.</description>
    <arm_group_label>Early information</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aortic valve area &lt; 1cm2

          -  Indexed aortic valve area &lt;0.6 cm/m2

          -  Maximum Jet velocity &gt; 4.0 m/sec

          -  Mean transvalvular gradient &gt; 40 mmHg

        Exclusion Criteria:

          -  Non-severe aortic Stenosis (AS)

          -  Previous aortic valve replacement (AVR)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Steeds, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen Elizabeth Hospital, Birmingham, UK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Norbert Frey, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiology and Angiology, University of Kiel, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Davia Messika-Zeitoun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Bichat, Paris FR</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peter Bramlage, Prof.Dr.med</last_name>
    <phone>+49(0)3379 3147892</phone>
    <email>peter.bramlage@ippmed.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Silvia Grafmueller, --</last_name>
    <phone>+49(0)4471 850324</phone>
    <email>silvia.grafmueller@ippmed.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Krankenhaus Hietzing</name>
      <address>
        <city>Wien</city>
        <zip>1130</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Adlbrecht, MD</last_name>
    </contact>
    <investigator>
      <last_name>Christopher Adlbrecht, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IKEM - Institute for Clinical and Experimental Medicine</name>
      <address>
        <city>Prag</city>
        <zip>140 21</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiri Maly, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jiri Maly, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier d'Annecy</name>
      <address>
        <city>Annecy</city>
        <zip>74374</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lionel Mangin, MD</last_name>
    </contact>
    <investigator>
      <last_name>Lionel Mangin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bichat Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Messika-Zeitoun, MD</last_name>
    </contact>
    <investigator>
      <last_name>David Messika-Zeitoun, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charité - Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>10233</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Lauten, MD</last_name>
    </contact>
    <investigator>
      <last_name>Alexander Lauten, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Erlangen</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Arnold, MD</last_name>
    </contact>
    <investigator>
      <last_name>Martin Arnold, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Westpfalz Klinikum</name>
      <address>
        <city>Kaiserslautern</city>
        <zip>67655</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Bernat, Prof</last_name>
    </contact>
    <investigator>
      <last_name>Robert Bernat, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UKSK Campus Kiel, Klinik für Kardiologie und Angiologie</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norbert Frey, Prof.Dr.med.</last_name>
      <phone>+49(0)431</phone>
      <phone_ext>5971440</phone_ext>
      <email>norbert.frey@uksh.de</email>
    </contact>
    <contact_backup>
      <last_name>Matthias Lutz, MD</last_name>
      <phone>+49(0)431</phone>
      <phone_ext>5971440</phone_ext>
      <email>matthias.lutz@uksh.de</email>
    </contact_backup>
    <investigator>
      <last_name>Norbert Frey, Prof.Dr.med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthias Lutz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Universitätsklinikum Köln</name>
      <address>
        <city>Köln</city>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Baldus, Prof</last_name>
    </contact>
    <investigator>
      <last_name>Stephan Baldus, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin der Johannes Gutenberg-Universität Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eberhard Schulz, Prof</last_name>
    </contact>
    <investigator>
      <last_name>Eberhard Schulz, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum München</name>
      <address>
        <city>München</city>
        <zip>80337</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johannes Rieber, MD</last_name>
    </contact>
    <investigator>
      <last_name>Johannes Rieber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus der Barmherzigen Brüder</name>
      <address>
        <city>Trier</city>
        <zip>54292</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl-Eugen Hauptmann, MD</last_name>
    </contact>
    <investigator>
      <last_name>Karl-Eugen Hauptmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Università degli Studi di Bari Aldo Moro</name>
      <address>
        <city>Bari</city>
        <zip>70121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annamaria Dachille, MD</last_name>
    </contact>
    <investigator>
      <last_name>Donato D'Agostino, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Annamaria Dachille, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University &quot;Magna Græcia&quot; of Catanzaro</name>
      <address>
        <city>Catanzaro</city>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ciro Indolfi, Prof</last_name>
    </contact>
    <investigator>
      <last_name>Ciro Indolfi, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS San Matteo Hospital</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marco Luigi Aiello, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marco Luigi Aiello, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico Umberto I Rom</name>
      <address>
        <city>Rom</city>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gennaro Sardella, Prof</last_name>
    </contact>
    <investigator>
      <last_name>Gennaro Sardella, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Torino</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mauro Rinaldi, Prof</last_name>
    </contact>
    <investigator>
      <last_name>Mauro Rinaldi, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AMC Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Berto Bouma, MD</last_name>
    </contact>
    <investigator>
      <last_name>Berto Bouma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Santa Creu Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonio Serra Peñaranda</last_name>
    </contact>
    <investigator>
      <last_name>Antonio Serra Peñaranda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UniversitätsSpital Zürich</name>
      <address>
        <city>Zürich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Maisano, Prof</last_name>
    </contact>
    <investigator>
      <last_name>Francesco Maisano, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2TH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Steeds, MD</last_name>
    </contact>
    <investigator>
      <last_name>Richard Steeds, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bart Heart Center</name>
      <address>
        <city>London</city>
        <zip>E1 1BB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guy Lloyd, MD</last_name>
    </contact>
    <investigator>
      <last_name>Guy Lloyd, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>James Cook University Hospital</name>
      <address>
        <city>Middlesbrough</city>
        <zip>TS4 3BW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeet Thambyrajah, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jeet Thambyrajah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Czech Republic</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>https://impulse.s4trials.de</url>
    <description>registry on-line eCRF website</description>
  </link>
  <verification_date>May 2016</verification_date>
  <lastchanged_date>May 18, 2016</lastchanged_date>
  <firstreceived_date>September 2, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>aortic valve Stenosis</keyword>
  <keyword>Echo</keyword>
  <keyword>TAVI</keyword>
  <keyword>SAVR</keyword>
  <keyword>referral</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
